- Home
- HOVR vs ANL Comparison
HOVR vs ANL Comparison
Compare HOVR & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOVR
- ANL
- Stock Information
- Founded
- HOVR 2013
- ANL 2004
- Country
- HOVR Canada
- ANL Cayman Islands
- Employees
- HOVR N/A
- ANL N/A
- Industry
- HOVR Blank Checks
- ANL
- Sector
- HOVR Finance
- ANL
- Exchange
- HOVR Nasdaq
- ANL Nasdaq
- Market Cap
- HOVR 62.1M
- ANL 61.8M
- IPO Year
- HOVR N/A
- ANL 2023
- Fundamental
- Price
- HOVR $2.03
- ANL $1.76
- Analyst Decision
- HOVR Strong Buy
- ANL Hold
- Analyst Count
- HOVR 1
- ANL 1
- Target Price
- HOVR $2.00
- ANL N/A
- AVG Volume (30 Days)
- HOVR 781.0K
- ANL 9.0K
- Earning Date
- HOVR 10-09-2025
- ANL 09-30-2025
- Dividend Yield
- HOVR N/A
- ANL N/A
- EPS Growth
- HOVR N/A
- ANL N/A
- EPS
- HOVR 0.12
- ANL N/A
- Revenue
- HOVR N/A
- ANL N/A
- Revenue This Year
- HOVR N/A
- ANL N/A
- Revenue Next Year
- HOVR N/A
- ANL N/A
- P/E Ratio
- HOVR $16.30
- ANL N/A
- Revenue Growth
- HOVR N/A
- ANL N/A
- 52 Week Low
- HOVR $0.24
- ANL $1.10
- 52 Week High
- HOVR $2.52
- ANL $3.89
- Technical
- Relative Strength Index (RSI)
- HOVR 67.50
- ANL 56.22
- Support Level
- HOVR $1.67
- ANL $1.68
- Resistance Level
- HOVR $1.78
- ANL $1.87
- Average True Range (ATR)
- HOVR 0.13
- ANL 0.11
- MACD
- HOVR 0.02
- ANL -0.00
- Stochastic Oscillator
- HOVR 95.83
- ANL 41.83
About HOVR New Horizon Aircraft Ltd.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and aiming to build a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, Floods and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.